Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 1.35 HKD Market Closed
Market Cap: 12.4B HKD

Wall Street
Price Targets

Price Targets Summary
Sihuan Pharmaceutical Holdings Group Ltd

There are no price targets for Sihuan Pharmaceutical Holdings Group Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sihuan Pharmaceutical Holdings Group Ltd Competitors:
Price Targets
LQDA
Liquidia Corp
14% Upside
HROW
Harrow Health Inc
50% Upside
VENUSREM
Venus Remedies Ltd
57% Downside
LABB
Genomma Lab Internacional SAB de CV
63% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
6% Downside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
37% Upside
512
Grand Pharmaceutical Group Ltd
53% Upside
GTII
Green Thumb Industries Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Sihuan Pharmaceutical Holdings Group Ltd

For the last 13 years the compound annual growth rate for Sihuan Pharmaceutical Holdings Group Ltd's revenue is -1%. The projected CAGR for the next 1 year is 34%.

-1%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sihuan Pharmaceutical Holdings Group Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Sihuan Pharmaceutical Holdings Group Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sihuan Pharmaceutical Holdings Group Ltd's stock price target?
Not Available

Sihuan Pharmaceutical Holdings Group Ltd doesn't have any price targets made by Wall Street professionals.

What is Sihuan Pharmaceutical Holdings Group Ltd's Revenue forecast?
Projected CAGR
34%

For the last 13 years the compound annual growth rate for Sihuan Pharmaceutical Holdings Group Ltd's revenue is -1%. The projected CAGR for the next 1 year is 34%.

Back to Top